230 related articles for article (PubMed ID: 34545187)
1. The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.
Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187
[TBL] [Abstract][Full Text] [Related]
2. A cytoplasmic role of Wnt/β-catenin transcriptional cofactors Bcl9, Bcl9l, and Pygopus in tooth enamel formation.
Cantù C; Pagella P; Shajiei TD; Zimmerli D; Valenta T; Hausmann G; Basler K; Mitsiadis TA
Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174279
[TBL] [Abstract][Full Text] [Related]
3. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma.
Huge N; Sandbothe M; Schröder AK; Stalke A; Eilers M; Schäffer V; Schlegelberger B; Illig T; Vajen B; Skawran B
Hepatol Int; 2020 May; 14(3):373-384. PubMed ID: 31440992
[TBL] [Abstract][Full Text] [Related]
4. Parsing β-catenin's cell adhesion and Wnt signaling functions in malignant mammary tumor progression.
Buechel D; Sugiyama N; Rubinstein N; Saxena M; Kalathur RKR; Lüönd F; Vafaizadeh V; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34408016
[TBL] [Abstract][Full Text] [Related]
5. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
[TBL] [Abstract][Full Text] [Related]
6. Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development.
Cantù C; Zimmerli D; Hausmann G; Valenta T; Moor A; Aguet M; Basler K
Genes Dev; 2014 Sep; 28(17):1879-84. PubMed ID: 25184676
[TBL] [Abstract][Full Text] [Related]
7. Mutations in
Cantù C; Felker A; Zimmerli D; Prummel KD; Cabello EM; Chiavacci E; Méndez-Acevedo KM; Kirchgeorg L; Burger S; Ripoll J; Valenta T; Hausmann G; Vilain N; Aguet M; Burger A; Panáková D; Basler K; Mosimann C
Genes Dev; 2018 Nov; 32(21-22):1443-1458. PubMed ID: 30366904
[TBL] [Abstract][Full Text] [Related]
8. BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.
Wang X; Feng M; Xiao T; Guo B; Liu D; Liu C; Pei J; Liu Q; Xiao Y; Rosin-Arbesfeld R; Shi Y; Zhou Y; Yang M; Feng YX; Jiang Y; Shao Z; Yu K; Zhu D
Oncogene; 2021 Apr; 40(16):2982-2997. PubMed ID: 33767438
[TBL] [Abstract][Full Text] [Related]
9. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
10. Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.
Deka J; Wiedemann N; Anderle P; Murphy-Seiler F; Bultinck J; Eyckerman S; Stehle JC; André S; Vilain N; Zilian O; Robine S; Delorenzi M; Basler K; Aguet M
Cancer Res; 2010 Aug; 70(16):6619-28. PubMed ID: 20682801
[TBL] [Abstract][Full Text] [Related]
11. The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells.
El-Hage P; Petitalot A; Monsoro-Burq AH; Maczkowiak F; Driouch K; Formstecher E; Camonis J; Sabbah M; Bièche I; Lidereau R; Lallemand F
Mol Cancer Res; 2015 May; 13(5):902-12. PubMed ID: 25678599
[TBL] [Abstract][Full Text] [Related]
12. The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis.
Zatula N; Wiese M; Bunzendahl J; Birchmeier W; Perske C; Bleckmann A; Brembeck FH
Oncotarget; 2014 Aug; 5(16):6770-87. PubMed ID: 25149534
[TBL] [Abstract][Full Text] [Related]
13. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
Zhang Y; Zhang Q; Chen H; Wang C
Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
[TBL] [Abstract][Full Text] [Related]
14. BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
Hoffmans R; Basler K
Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272
[TBL] [Abstract][Full Text] [Related]
15. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.
Sustmann C; Flach H; Ebert H; Eastman Q; Grosschedl R
Mol Cell Biol; 2008 May; 28(10):3526-37. PubMed ID: 18347063
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway.
Li B; Cai S; Zhao Y; He Q; Yu X; Cheng L; Zhang Y; Hu X; Ke M; Chen S; Zou M
Oncotarget; 2016 Dec; 7(49):81026-81048. PubMed ID: 27835587
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades.
Katoh M; Katoh M
Cancer Biol Ther; 2006 Sep; 5(9):1059-64. PubMed ID: 16940750
[TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
[TBL] [Abstract][Full Text] [Related]
19. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
de la Roche M; Worm J; Bienz M
BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
